Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
30.8M
-
Shares change
-
-4.45M
-
Total reported value, excl. options
-
$101M
-
Value change
-
-$24.7M
-
Put/Call ratio
-
0.45
-
Number of buys
-
41
-
Number of sells
-
-36
-
Price
-
$3.26
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2021
121 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2021.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.8M shares
of 129M outstanding shares and own 23.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.55M shares), VANGUARD GROUP INC (7.06M shares), STATE STREET CORP (2.15M shares), GEODE CAPITAL MANAGEMENT, LLC (2.11M shares), Nuveen Asset Management, LLC (1.59M shares), NORTHERN TRUST CORP (1.08M shares), CITADEL ADVISORS LLC (1.02M shares), D. E. Shaw & Co., Inc. (896K shares), Bank of New York Mellon Corp (477K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (299K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.